spot_img
29 C
Philippines
Thursday, March 28, 2024

Male CEO explains women’s intimacy issues

- Advertisement -

A woman may have to deal with a health condition that  affects not only her physical well-being but also the way she expresses her sexuality and emotional contentment.

Not a few have been afflicted with this condition which in layman’s term is known as feminine sexual dysfunction. Women who encounter these symptoms often simply ignore them, leading to more serious physical symptoms and deeper emotional and social dissatisfaction.

“This problem is there whether you talk about it or not. Somebody or something has to address that. We have a very focused approach to women’s health, which is one of our focus segments,” says Javed Ghulam Mohammad, chief executive of AJ Research & Pharma Sdn. Bhd., the distributor of feminine intimacy gel V-Sense.

AJ Research & Pharma is an innovative Malaysia-based pharmaceutical, cosmeceutical and nutraceutical company.  It seeks to address unmet needs in the healthcare market, and FSD is one of those concerns that the company has identified as a top priority especially within the emerging Asean market.

Mohammad says V-sense is one of the sensational products in Europe and is “one of the most excellent products that can help women resolve intimacy issues.”

- Advertisement -

An innovative feminine intimacy product, V-sense is the first intimate gel product in the Philippine market capable of restoring natural moisture in the female intimate area as it intensifies sensitivity and help women address symptoms of FSD. 

The product is specially patented and developed in Italy using natural ingredients derived from plants such as visnadine.

Mohammad says the product is backed by massive collection of clinical data attesting to its efficacy.

While it may be true that such conditions as vaginal dryness and lack of sexual interest are often associated with menopause among more mature women, FSD can occur at any age or stage in life.

AJ Research & Pharma Sdn. Bhd. chief executive  Javed Ghulam Mohammad

Mohammad says FSD is easy to address with proper support system and guidance from a health professional.

Medical treatment involving hormone therapy can be prescribed especially for patients with underlying medical conditions but may come with some risks and undesirable side effects, and must be undertaken only under the guidance of a doctor.

There are also numerous non-medical treatments and lifestyle strategies to overcome FSD, one of which is open communication. 

Dialog with one’s partner is key to understanding one’s own body and sexual needs as well. Learn or develop a system of communication to enhance intimacy not just physically but emotionally as well.  

Counseling or the professional guidance of a psychologist or medical professional may provide more effective and efficient communication and self-awareness exercises, techniques and tools.

Healthy living is another.  An overall lifestyle of health and wellness, limited alcohol intake and regular physical activity and exercise can also increase stamina, lighten mood and eliminate stress.

“In the Philippines, you see that the women population is pretty strong. They are working women, leaders in their field. But there must be something there the bothers them. There is a big possibility that whatever ails them may have something to do with FSD,” Mohammad says.

According to data, as much as 43 percent of adult women have experienced at least one manifestation of FSD at one point in their lives.

Symptoms of FSD include the inability to achieve orgasm; low desire to engage in sex; difficulty with sexual response or arousal; and physical conditions such as poor vaginal lubrication and pain.

After its Philippine debut, AJ Research will also launch V-Sense in Dubai, Vietnam and Singapore.

AJ Research & Pharma has recently completed the acquisition of Pascual Total Health Inc. to manage the distribution of AJ’s proprietary products as well as European wellness products to the Philippines.

This year, the Malaysian pharmaceutical company will start bringing at least 25 to 30 new products through the tail-end of 2017.

“We have a big range of pharmaceutical products that we are introducing every quarter. One of these is moxifloxacin, a high-end, very potent antibiotic and a drug for erectile dysfunction in a different form plus cardiovascular and central nervous system portfolio. Pediatric chewables with lysine and  taurine for kids wil be introduced in 5 different variants and at least 5 more products under derma aesthetics,” Mohammad says.

AJ Research via Pascual Total Health is distributing 15 pharmaceutical products in the Philippines.

The company is very aggressive with the quarterly launches, collaborating with US and European pharmaceutical companies for new products it can market  globally.

“The board is very happy with Philippine operations. We are willing to invest more in this country, whether another acquisition or setting up of manufacturing facilities. We’re looking for brand acquisition as well, although we’re not in active discussions with any brand yet,” says Mohammad.

- Advertisement -

LATEST NEWS

Popular Articles